Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technetium-labeled Cimzia scintigraphy-guided biologic selection after TNF inhibitor failure in rheumatoid arthritis
2016-004300-65Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Jan 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of certolizumab pegol, abatacept and tocilizumab in rheumatoid arthritis (RA) (2 arms), sponsored by Ghent University Hospital. Started Jan 2017; status: completed.
02
Drugs
certolizumab pegolabatacepttocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2016-004300-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004300-65.